Adductor Canal Block in an Enhanced Recovery Program After Total Knee Arthroplasty
Total Knee Arthroplasty, Knee Osteoarthritis
About this trial
This is an interventional treatment trial for Total Knee Arthroplasty focused on measuring total kee arthroplasty, adductor canal block, multimodal analgesia
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing elective unilateral total knee arthroplasty
- American Society of Anesthesiologist (ASA) class 1-3
- Adults aged 18-85 years old
Exclusion Criteria:
- Contraindications of the adductor canal block.
- Contraindications of the local infiltration analgesia technique.
- Chronic kidney disease
- Surgery to be performed under general anesthesia.
- Opioid treatment > 30 mgr morphine or equivalent for more than 3 months time.
- Neuropathic ipsilateral pain.
- Inability to understand study procedures.
- Not acceptance of the procedure (adductor canal block or local infiltration analgesia).
Sites / Locations
- Hospital Universitary Santa MariaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Adductor Canal Block
Placebo Comparator
Patients will receive multi-modal analgesia (oral, intravenous and local infiltration anesthesia) for pain management following total knee arthroplasty and in the first postoperative day a single adductor canal block wiht 20cc of 0.5% Ropivacaine using ultrasound guidance .
Patients will receive multi-modal analgesia (oral, intravenous and local infiltration anesthesia) for pain management following total knee arthroplasty and in the first postoperative day a sham adductor canal block with 2ml of 1% subcutaneous lidocaine at the level of the adductor canal using ultrasound guidance.